Safety Differences Across Androgen Receptor Inhibitors in Nonmetastatic Castration-Resistant Prostate Cancer
Open Access
- 16 February 2023
- journal article
- review article
- Published by Taylor & Francis in Future Oncology
- Vol. 19 (5) , 385-395
Abstract
Approval of apalutamide, enzalutamide and darolutamide has transformed the treatment landscape and guideline recommendations for patients with nonmetastatic castration-resistant prostate cancer but... Plain language summary Prostate cancer is one of the most common cancers in men. Because male hormones fuel the growth of prostate cancer cells, initial treatments generally focus on reducing these... Tweetable abstract Key safety differences exist among second-generation androgen receptor inhibitors for nonmetastatic castration-resistant prostate cancer. We discuss these differences and their p...Keywords
Funding Information
- Bayer
This publication has 53 references indexed in Scilit:
- Falls and Frailty in Prostate Cancer Survivors: Current, Past, and Never Users of Androgen Deprivation TherapyJournal of the American Geriatrics Society, 2017
- PSMA-Based [18F]DCFPyL PET/CT Is Superior to Conventional Imaging for Lesion Detection in Patients with Metastatic Prostate CancerMolecular Imaging and Biology, 2016
- Prevalence of Prostate Cancer Clinical States and Mortality in the United States: Estimates Using a Dynamic Progression ModelPLOS ONE, 2015
- Comorbidities and Concomitant Medication Use in Men with Prostate Cancer or High Levels of PSA Compared to Matched Controls: A GPRD AnalysisJournal of Cancer Epidemiology, 2012
- The prescribing cascadeAustralian Prescriber, 2011
- Impact of Biochemical Recurrence in Prostate Cancer Among US VeteransArchives of internal medicine (1960), 2010
- Gonadotropin-Releasing Hormone Agonists and Fracture Risk: A Claims-Based Cohort Study of Men With Nonmetastatic Prostate CancerJournal of Clinical Oncology, 2005
- Risk of Fracture after Androgen Deprivation for Prostate CancerNew England Journal of Medicine, 2005
- Optimising drug treatment for elderly people: the prescribing cascadeBMJ, 1997
- Physician Management of Patients With Adverse OutcomesArchives of internal medicine (1960), 1986